Roche Settles Patent Row With Intas Over Cancer Drug Xeloda
A New Jersey federal judge on Monday dismissed a Hoffmann-La Roche Inc. lawsuit contending Intas Pharmaceuticals Ltd. and a subsidiary infringed a patent for Roche's Xeloda cancer drug by seeking approval...To view the full article, register now.
Already a subscriber? Click here to view full article